The COVID-19 pandemic took the world by storm when it began in January 2020. Densely populated cities took a brutal hit with more significant percentages of infection, hospitalization, and death due to...
In the United States and worldwide, clinical trials play a vital role in developing, testing, approving, and rolling out medical interventions. In the US, the FDA monitors and regulates clinical trials, using the results to decide whether...
According to an announcement by the NHS, the first humans have been transfused with lab-grown red blood cells as part of the RESTORE trial. The RESTORE trial is a randomized clinical trial in which red...
On October 18, 2022, the United States Department of Health and Human Services (HHS) announced its plans to allocate new funding to combat the mental health crisis. Under the guidance of the Biden administration and the Bipartisan Safer...
Last month, Unilever North America voluntarily recalled multiple dry shampoo products, citing the presence of benzene in the propellant as the primary source. Since then, Valisure LLC, an independent...
According to a press statement released on October 18, 2022, the Treventis Corporation, a biotechnology company, was granted $2.97 million to research and develop an anti-tau misfolding drug. The press...
On October 17, 2022, the FDA announced that its Orphan Products Grants Program has awarded 19 grants and 2 contracts, amounting to over $38 million, for rare disease research. This action will...
Using data from ClinicalTrials.gov, researchers collected data on eligibility criteria from approximately 100 clinical research protocols. Of the 97 interventional studies, 14 focused on dementia, 24...
For many minority communities, marijuana possession and use can lead to years of incarceration for nonviolent offenses. The Biden administration has recognized that the harsh punishment around...
Many vitamins and supplements are readily available over the counter for patient use. Understanding the effects of supplements on healthcare can impact and inform physician practices for more effective...
Bridge to Artificial Intelligence (Bridge2AI) is an NIH Common Fund Program focused on combining machine learning and artificial intelligence to provide advancements in the biomedical industry. According to a market analysis report done by...
In a recent article published in Nature Medicine, researchers shared information on new biomarkers to develop HIV prevention tools. This publication highlighted research from the Antibody Mediated Prevention (AMP) trials. It is thought...
On August 25, 2022, the Biden administration announced its plans to ensure equitable access to research. Outlined in the press release are the administration’s intentions to make all federally funded research free and accessible by...
The Advanced Research Projects Agency for Health (ARPA-H) was proposed by the Biden Administration on March 15, 2022, as a government organization to drive biomedical and healthcare innovation. Under...
Glucocorticoids are widely prescribed for those struggling with autoimmune and neurological conditions and are considered one of the most prescribed drugs. In a study published in BMJ Open, researchers...
Wearable devices have gained much traction recently for their potential uses in the healthcare industry. Recently, Northwestern University has collaborated with Johns Hopkins University on a research...
An alarming pre-pandemic CDC study reveals that substance misuse is linked to mental health issues. The study investigated how many people pursuing treatment for substance misuse also reported...
Bristol Myers Squibb recently announced that its severe plaque psoriasis treatment, deucravacitinib, elicited durable efficacy and a consistent safety profile in adult...
Johnson & Johnson recently appointed Thibaut Mongon as chief executive officer and Paul Ruh as chief financial officer designate of its future consumer health company.
With over 20...
Novo Nordisk and Flagship Pioneering recently collaborated to create a portfolio of novel research programs to develop transformation metabolic and rare disease treatments.
The companies will apply...